{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T22:12:06Z","timestamp":1780092726999,"version":"3.54.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T00:00:00Z","timestamp":1706572800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Continuous-wave transscleral cyclophotocoagulation (CW-TSCP) is usually reserved for advanced\/refractory glaucoma. Micropulse transscleral laser therapy (MPTLT) utilises short energy pulses separated by \u2018<jats:italic>off<\/jats:italic>\u2019-periods. MPTLT is postulated to have fewer complications, but its relative efficacy is not known. The National Institute for Health and Care Excellence (NICE) has deemed the evidence supporting MPTLT use of inadequate quality, limiting its use to research. This study aims to evaluate MPTLT efficacy and safety compared to CW-TSCP.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This 24-month follow-up retrospective audit included 85 CW-TSCP and 173 MPTLT eyes at a London tertiary referral centre. Primary outcome was success rate at the last follow-up; defined as at least 20% intraocular pressure (IOP) reduction with the same\/fewer medications, and IOP between 6 and 18\u2009mmHg. Secondary outcomes were acetazolamide use and success rates per glaucoma type. Safety outcomes were reported as complication rates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>By 24-months, mean IOP reduced from 34.6[\u00b11.4]mmHg to 19.0[\u2009\u00b1\u20093.0]mmHg post-CW-TSCP (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001); and from 26.1[\u00b10.8]mmHg to 19.1[\u00b12.2]mmHg post-MPTLT (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Average IOP decreased by 45.1% post-CW-TSCP, and 26.8% post-MPTLT. Both interventions reduced medication requirements (<jats:italic>p<\/jats:italic>\u2009\u2264\u20090.05). More CW-TSCP patients discontinued acetazolamide (<jats:italic>p<\/jats:italic>\u2009=\u20090.047). Overall success rate was 26.6% for CW-TSCP and 30.6% for MPTLT (<jats:italic>p<\/jats:italic>\u2009=\u20090.83). Only primary closed-angle glaucoma saw a significantly higher success rate following CW-TSCP (<jats:italic>p<\/jats:italic>\u2009=\u20090.014). CW-TSCP complication rate was significantly higher than MPTLT (<jats:italic>p<\/jats:italic>\u2009=\u20090.0048).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Both treatments significantly reduced IOP and medication load. CW-TSCP had a greater absolute\/proportionate IOP-lowering effect, but it carried a significantly greater risk of sight-threatening complications. Further prospective studies are required to evaluate MPTLT compared to CW-TSCP.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1038\/s41433-024-02929-1","type":"journal-article","created":{"date-parts":[[2024,1,30]],"date-time":"2024-01-30T11:02:18Z","timestamp":1706612538000},"page":"1477-1484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cyclodiode vs micropulse transscleral laser treatment"],"prefix":"10.1038","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0993-901X","authenticated-orcid":false,"given":"Monica","family":"Kelada","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo M.","family":"Normando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca M.","family":"Cordeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Crawley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0015-6008","authenticated-orcid":false,"given":"Faisal","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Ameen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niten","family":"Vig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Bloom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,1,30]]},"reference":[{"key":"2929_CR1","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"H Quigley","year":"2006","unstructured":"Quigley H, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262\u20137.","journal-title":"Br J Ophthalmol"},{"key":"2929_CR2","first-page":"1719","volume":"34","author":"HE Killer","year":"2020","unstructured":"Killer HE, Pircher A. What is the optimal glaucoma treatment: reducing aqueous humour production or facilitating its outflow? Eye (Basingstoke) Springe Nat. 2020;34:1719\u201321.","journal-title":"Eye (Basingstoke) Springe Nat"},{"key":"2929_CR3","doi-asserted-by":"crossref","unstructured":"Tamm E The Role of the Ciliary Body in Aqueous Humor Dynamics Structural Aspects. In: Dartt Darlene A, editor. Encyclopedia of the Eye. p. 179\u201386. (2010).","DOI":"10.1016\/B978-0-12-374203-2.00085-3"},{"key":"2929_CR4","doi-asserted-by":"crossref","unstructured":"Evans M, Yanoff M, Duker J Anatomy of the Uvea. In: Yanoff M, editor. Ophthalmology. 5th ed. p. 689\u201391. (2019).","DOI":"10.1016\/B978-0-323-54755-0.00009-7"},{"key":"2929_CR5","doi-asserted-by":"crossref","unstructured":"Gelatt KN, Wilkie DA Chapter 9 - Surgical procedures of the anterior chamber and anterior uvea. In: Gelatt KN, Gelatt JP, editors. Veterinary Ophthalmic Surgery [Internet]. Edinburgh: W.B. Saunders; 2011. p. 237\u201362. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780702034299000092.","DOI":"10.1016\/B978-0-7020-3429-9.00009-2"},{"key":"2929_CR6","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/S0161-6420(96)30508-3","volume":"103","author":"O Kosoko","year":"1996","unstructured":"Kosoko O, Gaasterland DE, Pollack IP, Enger CL. Long, term outcome of initial ciliary ablation with contact diode laser t ransscleral cyclophotocoagulation for severe glaucoma. Ophthalmology. 1996;103:1294\u2013302.","journal-title":"Ophthalmology"},{"key":"2929_CR7","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1442-9071.2010.02238.x","volume":"38","author":"AM Tan","year":"2010","unstructured":"Tan AM, Chockalingam M, Aquino MC, Lim ZIL, See JLS, Chew PT. Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma. Clin Exp Ophthalmol. 2010;38:266\u201372.","journal-title":"Clin Exp Ophthalmol"},{"key":"2929_CR8","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1097\/IJG.0000000000001023","volume":"27","author":"A Yelenskiy","year":"2018","unstructured":"Yelenskiy A, Gillette TB, Arosemena A, Stern AG, Garris WJ, Young CT, et al. Patient outcomes following micropulse transscleral cyclophotocoagulation: Intermediate-term results. J Glaucoma. 2018;27:920\u20135.","journal-title":"J Glaucoma"},{"key":"2929_CR9","unstructured":"Allbon D, Meyer JJ. Cyclodiode laser glaucoma therapy. StatPearls. (2021). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK574570\/."},{"key":"2929_CR10","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1016\/S0161-6420(97)30109-2","volume":"104","author":"PA Bloom","year":"1997","unstructured":"Bloom PA, Tsai JC, Sharma K, Miller MH, Rice NSC, Hitchings RA, et al. \u201cCyclodiode\u201d Trans\u2026 scleral Diode laser cyclophotocoagulation in the treatment of advanced refractory glaucoma. Ophthalmology. 1997;104:1508\u201319.","journal-title":"Ophthalmology"},{"key":"2929_CR11","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1136\/bjo.2008.145565","volume":"94","author":"AP Rotchford","year":"2010","unstructured":"Rotchford AP, Jayasawal R, Madhusudhan S, Ho S, King AJ, Vernon SA. Transscleral diode laser cycloablation in patients with good vision. Br J Ophthalmol. 2010;94:1180\u20133.","journal-title":"Br J Ophthalmol"},{"key":"2929_CR12","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1038\/sj.eye.6702345","volume":"21","author":"E Ansari","year":"2007","unstructured":"Ansari E, Gandhewar J. Long-term efficacy and visual acuity following transscleral diode laser photocoagulation in cases of refractory and non-refractory glaucoma. Eye. 2007;21:936\u201340.","journal-title":"Eye"},{"key":"2929_CR13","first-page":"1834","volume":"31","author":"HD Schubert","year":"1990","unstructured":"Schubert HD, Agarwala A, Arbizo V. Changes in aqueous outflow after in vitro neodymium: yttrium aluminum garnet laser cyclophotocoagulation. Investig Ophthalmol Vis Sci. 1990;31:1834\u20138.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"2929_CR14","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/bjo.2005.082073","volume":"90","author":"PA Bloom","year":"2006","unstructured":"Bloom PA, Dharmaraj S. Endoscopic and transscleral cyclophotocoagulation. Br J Ophthalmol. 2006;90:665\u20136.","journal-title":"Br J Ophthalmol"},{"key":"2929_CR15","unstructured":"Malik KJ, Sampat KM, Mansouri A, Steiner JN, Glaser BM. Low-intensity\/high-density subthreshold micropulse diode laser for chronic central serous chorioretinopathy [Internet]. Available from: http:\/\/journals.lww.com\/retinajournal."},{"key":"2929_CR16","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/ceo.12360","volume":"43","author":"MCD Aquino","year":"2015","unstructured":"Aquino MCD, Barton K, Tan AMWT, Sng C, Li X, Loon SC, et al. Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: A randomized exploratory study. Clin Exp Ophthalmol. 2015;43:40\u20136.","journal-title":"Clin Exp Ophthalmol"},{"key":"2929_CR17","first-page":"2825","volume":"60","author":"MA Johnstone","year":"2019","unstructured":"Johnstone MA, Song S, Padilla S, Wen K, Xin C, Wen JC, et al. Microscope real-time video (MRTV), high- resolution OCT (HR-OCT) & histopathology (HP) to assess how transcleral micropulse laser (TML) affects the sclera, ciliary body (CB), muscle (CM), secretory epithelium (CBSE), suprachoroidal space (SCS) & aqueous outflow system. Invest Ophthalmol Vis Sci. 2019;60:2825.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2929_CR18","unstructured":"NICE. Repetitive short-pulse transscleral cyclophotocoagulation for glaucoma Interventional procedures guidance Your responsibility Your responsibility [Internet]. 2021. Available from: www.nice.org.uk\/guidance\/ipg692."},{"key":"2929_CR19","unstructured":"National Institute for Health and Care Excellence IP1779 Repetitive short-pulse transscleral cyclophotocoagulation for glaucoma [Internet]. 2021. Available from: https:\/\/www.nice.org.uk\/guidance\/ng81\/chapter\/Recomm."},{"key":"2929_CR20","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.2147\/OPTH.S365647","volume":"ume 16","author":"TM Grippo","year":"2022","unstructured":"Grippo TM, de Crom RM, Giovingo M, T\u00f6teberg-Harms M, Francis BA, Jerkins B, et al. Evidence-based consensus guidelines series for micropulse transscleral laser therapy: dosimetry and patient selection. Clin Ophthalmol. 2022;ume 16:1837\u201346.","journal-title":"Clin Ophthalmol"},{"key":"2929_CR21","unstructured":"NICE. Glaucoma: diagnosis and management NICE guideline [Internet]. 2017. Available from: www.nice.org.uk\/guidance\/ng81."},{"key":"2929_CR22","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1007\/s00417-020-04611-0","volume":"258","author":"N Vig","year":"2020","unstructured":"Vig N, Ameen S, Bloom P, Crawley L, Normando E, Porteous A, et al. Micropulse transscleral cyclophotocoagulation: initial results using a reduced energy protocol in refractory glaucoma. Graefe\u2019s Arch Clin Exp Ophthalmol. 2020;258:1073\u20139.","journal-title":"Graefe\u2019s Arch Clin Exp Ophthalmol"},{"key":"2929_CR23","unstructured":"Iridex. Iridex Cyclo G6 \u00ae Laser System Operator Manual. (2021)."},{"key":"2929_CR24","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/IJG.0000000000001053","volume":"27","author":"AM Abdelrahman","year":"2018","unstructured":"Abdelrahman AM, El Sayed YM. Micropulse versus continuous wave transscleral cyclophotocoagulation in refractory pediatric glaucoma. J Glaucoma. 2018;27:900\u20135.","journal-title":"J Glaucoma"},{"key":"2929_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.jcjo.2021.01.015","volume":"56","author":"M Marchand","year":"2021","unstructured":"Marchand M, Singh H, Agoumi Y. Micropulse trans-scleral laser therapy outcomes for uncontrolled glaucoma: a prospective 18-month study. Can J Ophthalmol. 2021;56:371\u20138.","journal-title":"Can J Ophthalmol"},{"key":"2929_CR26","doi-asserted-by":"publisher","first-page":"E314","DOI":"10.1097\/IJG.0000000000001882","volume":"30","author":"A Rabiolo","year":"2021","unstructured":"Rabiolo A, Leadbetter D, Anand N. Hypotony-associated complications after deep sclerectomy: incidence, risk factors, and long-term outcomes. J Glaucoma. 2021;30:E314\u201326.","journal-title":"J Glaucoma"},{"key":"2929_CR27","first-page":"477","volume":"28","author":"CB Toris","year":"1987","unstructured":"Toris CB, Pederson JE. Aqueous humor dynamics in experimental iridocyclitis. Invest Ophthalmol Vis Sci. 1987;28:477\u201381.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2929_CR28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/IJG.0000000000000934","volume":"27","author":"AL Williams","year":"2018","unstructured":"Williams AL, Moster MR, Rahmatnejad K, Resende AF, Horan T, Reynolds M, et al. Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma. J Glaucoma. 2018;27:445\u20139.","journal-title":"J Glaucoma"},{"key":"2929_CR29","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10792-017-0782-1","volume":"39","author":"JJC Cheung","year":"2019","unstructured":"Cheung JJC, Li KKW, Tang SWK. Retrospective review on the outcome and safety of transscleral diode laser cyclophotocoagulation in refractory glaucoma in Chinese patients. Int Ophthalmol. 2019;39:41\u20136.","journal-title":"Int Ophthalmol"},{"key":"2929_CR30","unstructured":"Shaarawy T, Grehn F, Sherwood M, World Glaucoma Association. WGA guidelines on design and reporting of glaucoma surgical trials. Kugler Publications; 83 p. (2009)."},{"key":"2929_CR31","doi-asserted-by":"crossref","unstructured":"Yap TE, Ahmed F, Bloom PA Re: Gedde et al.: Treatment outcomes in the Primary Tube Versus Trabeculectomy (PTVT) study after 3 years of follow-up (Ophthalmology. 127:333\u2013345). Vol. 127, Ophthalmology. Elsevier Inc.; 2020. p. e80\u20131. (2020).","DOI":"10.1016\/j.ophtha.2020.04.024"},{"key":"2929_CR32","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1177\/1120672119877586","volume":"31","author":"S Souissi","year":"2021","unstructured":"Souissi S, Baudouin C, Labb\u00e9 A, Hamard P. Micropulse transscleral cyclophotocoagulation using a standard protocol in patients with refractory glaucoma naive of cyclodestruction. Eur J Ophthalmol. 2021;31:112\u20139.","journal-title":"Eur J Ophthalmol"},{"key":"2929_CR33","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1111\/j.1442-9071.2006.01339.x","volume":"34","author":"R Malik","year":"2006","unstructured":"Malik R, Ellingham RB, Suleman H, Morgan WH. Refractory glaucoma - Tube or diode? Clin Exp Ophthalmol. 2006;34:771\u20137.","journal-title":"Clin Exp Ophthalmol"},{"key":"2929_CR34","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1159\/000070635","volume":"217","author":"V Pucci","year":"2003","unstructured":"Pucci V, Tappainer F, Borin S, Bellucci R. Long-term follow-up after transscleral diode laser photocoagulation in refractory glaucoma. Ophthalmol [Internet]. 2003;217:279\u201383. https:\/\/www.karger.com\/DOI\/10.1159\/000070635.","journal-title":"Ophthalmol [Internet]"},{"key":"2929_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1136\/bjo.83.3.311","volume":"83","author":"AF Spencer","year":"1999","unstructured":"Spencer AF, Vernon SA. Cyclodiode\u201d: results of a standard protocol. Br J Ophthalmol. 1999;83:311\u20136.","journal-title":"Br J Ophthalmol"},{"key":"2929_CR36","first-page":"191","volume":"116","author":"CO Okeke","year":"2009","unstructured":"Okeke CO, Quigley HA, Jampel HD, Ying Gshuang, Plyler RJ, Jiang Y, et al. Adherence with topical glaucoma medication monitored electronically. Travatan Dosing Aid Study Ophthalmol. 2009;116:191\u20139.","journal-title":"Travatan Dosing Aid Study Ophthalmol"},{"key":"2929_CR37","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1136\/bjo.2004.048710","volume":"89","author":"BEK Klein","year":"2005","unstructured":"Klein BEK, Klein R, Knudtson MD. Intraocular pressure and systemic blood pressure: Longitudinal perspective: The Beaver Dam Eye Study. Br J Ophthalmol. 2005;89:284\u20137.","journal-title":"Br J Ophthalmol"},{"key":"2929_CR38","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1136\/bjo.59.12.717","volume":"59","author":"CJ Bulpitt","year":"1975","unstructured":"Bulpitt CJ, Hodes C, Everitt MG. Intraocular pressure and systemic blood pressure in the elderly. Br J Ophthalmol. 1975;59:717\u201320.","journal-title":"Br J Ophthalmol"},{"key":"2929_CR39","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3961\/jpmph.2011.44.4.157","volume":"44","author":"S Biswas","year":"2011","unstructured":"Biswas S, Raman R, Koluthungan V, Sharma T. Intraocular pressure and its determinants in subjects with type 2 diabetes mellitus in India. J Prevent Med Public Health. 2011;44:157\u201366.","journal-title":"J Prevent Med Public Health"},{"key":"2929_CR40","doi-asserted-by":"crossref","unstructured":"Madjedi KM, Stuart KV, Chua SYL, Luben RN, Warwick A, Pasquale LR, et al. The association between serum lipids and intraocular pressure in two large UK cohorts. Ophthalmology [Internet]. 2022;129:986\u2013996. https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642022003116.","DOI":"10.1016\/j.ophtha.2022.01.023"},{"key":"2929_CR41","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1097\/IJG.0000000000000715","volume":"26","author":"ME Emanuel","year":"2017","unstructured":"Emanuel ME, Grover DS, Fellman RL, Godfrey DG, Smith O, Butler MR, et al. Micropulse cyclophotocoagulation: initial results in refractory glaucoma. J Glaucoma. 2017;26:726\u20139.","journal-title":"J Glaucoma"},{"key":"2929_CR42","doi-asserted-by":"crossref","unstructured":"Abdelmassih Y, Tomey K, Khoueir Z Micropulse transscleral cyclophotocoagulation. Journal of Current Glaucoma Practice. Jaypee Brothers Medical Publishers (P) Ltd; p. Vol. 15, 1\u20137. (2021).","DOI":"10.5005\/jp-journals-10078-1298"},{"key":"2929_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1167\/tvst.9.5.22","volume":"9","author":"K Moussa","year":"2020","unstructured":"Moussa K, Feinstein M, Pekmezci M, Lee JH, Bloomer M, Oldenburg C, et al. Histologic changes following continuous wave and micropulse transscleral cyclophotocoagulation: A randomized comparative study. Transl Vis Sci Technol. 2020;9:1\u20139.","journal-title":"Transl Vis Sci Technol"},{"key":"2929_CR44","doi-asserted-by":"publisher","first-page":"144","DOI":"10.22336\/rjo.2018.21","volume":"61","author":"R Barac","year":"2018","unstructured":"Barac R, Vuzitas M, Balta F. Choroidal thickness increase after micropulse transscleral cyclophotocoagulation. Rom J Ophthalmol. 2018;61:144\u20138.","journal-title":"Rom J Ophthalmol"},{"key":"2929_CR45","doi-asserted-by":"crossref","unstructured":"Schlote T, Derse M, Rassmann K, Nicaeus T, Dietz K, Thiel HJ. Efficacy and Safety of Contact Transscleral Diode Laser Cyclophotocoagulation for Advanced Glaucoma [Internet]. 2001. Available from: http:\/\/journals.lww.com\/glaucomajournal.","DOI":"10.1097\/00061198-200108000-00009"},{"key":"2929_CR46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/ICU.0b013e32835d9335","volume":"24","author":"K Ishida","year":"2013","unstructured":"Ishida K. Update on results and complications of cyclophotocoagulation. Curr Opin Ophthalmol. 2013;24:102\u201310.","journal-title":"Curr Opin Ophthalmol"},{"key":"2929_CR47","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1097\/IJG.0000000000001443","volume":"29","author":"KYT Wong","year":"2020","unstructured":"Wong KYT, Aquino CM, Macasaet AM, Suwandono ME, Chew PTK, Koh VTC. MP3 plus: a modified micropulse transscleral cyclophototherapy technique for the treatment of refractory glaucoma. J Glaucoma. 2020;29:264\u201370.","journal-title":"J Glaucoma"},{"key":"2929_CR48","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1177\/1120672120914231","volume":"31","author":"O Tekeli","year":"2021","unstructured":"Tekeli O, K\u00f6se HC. Outcomes of micropulse transscleral cyclophotocoagulation in primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma. Eur J Ophthalmol. 2021;31:1113\u201321.","journal-title":"Eur J Ophthalmol"},{"key":"2929_CR49","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.2014.3192","volume":"311","author":"RN Weinreb","year":"2014","unstructured":"Weinreb RN, Aung T, Medeiros FA. The pathophysiology and treatment of glaucoma: a review. JAMA\u2014J Am Med Assoc Am Med Assoc. 2014;311:1901\u201311.","journal-title":"JAMA\u2014J Am Med Assoc Am Med Assoc"},{"key":"2929_CR50","doi-asserted-by":"crossref","unstructured":"Schmack I, V\u00f6lcker HE, Grossniklaus HE Chapter 54 - Phthisis bulbi. In: Levin LA, Albert DM, editors. Ocular Disease [Internet]. Edinburgh: W.B. Saunders; 2010. p. 415\u201323. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/B9780702029837000541.","DOI":"10.1016\/B978-0-7020-2983-7.00054-1"},{"key":"2929_CR51","doi-asserted-by":"crossref","unstructured":"Feldman R, El-Harazi SM, LoRusso FJ, McCash C, Warner PA. Histopathologic findings following contact transscleral semiconductor diode laser cyclophotocoagulation in a human eye. J Glaucoma. 1997;6:139\u201340.","DOI":"10.1097\/00061198-199704000-00011"},{"key":"2929_CR52","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.6084\/m9.figshare.7291136","volume":"35","author":"AI Dastiridou","year":"2018","unstructured":"Dastiridou AI, Katsanos A, Denis P, Francis BA, Mikropoulos DG, Teus MA, Konstas AG. Cyclodestructive procedures in glaucoma: a review of current and emerging options. Adv Ther [Internet]. 2018;35:2103\u20132127. https:\/\/doi.org\/10.6084\/m9.figshare.7291136.","journal-title":"Adv Ther [Internet]"},{"key":"2929_CR53","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1097\/IJG.0000000000001925","volume":"30","author":"W Tong","year":"2021","unstructured":"Tong W, Shen T, Aquino M, Chew P, Lim D. One-year outcomes of micropulse cyclophototherapy for primary open-angle glaucoma. J Glaucoma. 2021;30:911\u201320.","journal-title":"J Glaucoma"},{"key":"2929_CR54","doi-asserted-by":"publisher","first-page":"251584142110105","DOI":"10.1177\/25158414211010549","volume":"13","author":"BK Lakhani","year":"2021","unstructured":"Lakhani BK, Attzs MS, Stead R, Tambe K. The impact of the COVID-19 pandemic on ophthalmology services across the United Kingdom: a brief report on a cross-sectional survey of clinical leads. Ther Adv Ophthalmol [Internet]. 2021;13:25158414211010548 https:\/\/doi.org\/10.1177\/25158414211010549.","journal-title":"Ther Adv Ophthalmol [Internet]"},{"key":"2929_CR55","doi-asserted-by":"publisher","unstructured":"Holland LJ, Mercieca KJ, Kirwan JF. Effect of COVID-19 pandemic on glaucoma surgical practices in the UK. Br J Ophthalmol. 2022;106:1406\u20131410. https:\/\/doi.org\/10.1136\/bjophthalmol-2021-319062.","DOI":"10.1136\/bjophthalmol-2021-319062"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-02929-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-02929-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-02929-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T17:05:37Z","timestamp":1716570337000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-024-02929-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,30]]},"references-count":55,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["2929"],"URL":"https:\/\/doi.org\/10.1038\/s41433-024-02929-1","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,30]]},"assertion":[{"value":"9 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PB received consultancy fees from BVI and travelling expenses and honoraria from Iridex. EMN has received travelling expenses from Iridex. MK, FMC, LC, FA, SA, NV declare no potential conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}